HALO logo
halo search icon
13
HUTCHMED (China) Limited

13 · HUTCHMED (China) Limited

21.54

HKD
-0.26 (-1.193%)
18/09/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

HK$19.02B

PE

5.10

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

3Neutral

As at 18/09/2026 12:00:00 AM

Price Chart

Description

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • EMA 125 Breakup
  • HALO All
  • HALO Earnings Momentum
  • HALO Small
  • Recent Earnings upgrade
  • Recent Price upgrade
  • Short Term Trend - Long

Key Fundamentals

EPS 3 yr Growth

-225.00%

EBITDA Margin

-5.90%

Operating Cashflow

-$65m

Free Cash Flow Return

-6.10%

ROIC

43.00%

Interest Coverage

-11.30

Quick Ratio

4.80

Performance

52 weeks range

Low 15.57 - 28.1

Trade Value (12mth)

US$3,368,694.00

1 week

3.61%

1 month

10.32%

YTD

4.11%

1 year

-13.08%

All time high

85.80

Additional Data

Shares Outstanding (Fully Diluted)

873m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Strong

Event

Neutral

Halo Model

Mqv

Neutral

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Neutral

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
CK Hutchison Holdings Ltd.Public Company
Wei Guo SuIndividual
Invesco Great Wall Fund Management Co. Ltd.Joint Venture
Chig Fung ChengIndividual
Edith ShihIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of HUTCHMED (China) Limited (13:HKG)?
Halo FAQ
The current share price of HUTCHMED (China) Limited (13:HKG) is HKDHK$21.54.
2
What is the 52-week high share price for HUTCHMED (China) Limited (13:HKG)?
Halo FAQ
The 52-week high share price for HUTCHMED (China) Limited (13:HKG) is HKDHK$28.10.
3
What is the 52-week low share price for HUTCHMED (China) Limited (13:HKG)?
Halo FAQ
The 52-week low share price for HUTCHMED (China) Limited (13:HKG) is HKDHK$15.57.
4
What is the dividend yield for HUTCHMED (China) Limited (13:HKG)?
Halo FAQ
HUTCHMED (China) Limited (13:HKG) does not pay a dividend.
5
What was HUTCHMED (China) Limited (13:HKG) last dividend payment?
Halo FAQ
HUTCHMED (China) Limited (13:HKG) does not pay a dividend.
6
What is the franking level for HUTCHMED (China) Limited (13:HKG)?
Halo FAQ
HUTCHMED (China) Limited (13:HKG) has a franking level of 0.00%.
7
In which sector is HUTCHMED (China) Limited (13:HKG) classified?
Halo FAQ
HUTCHMED (China) Limited (13:HKG) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for HUTCHMED (China) Limited (13:HKG)?
Halo FAQ
The current P/E ratio for HUTCHMED (China) Limited (13:HKG) is 5.10.